A Rationale for Relaxing the Requirement to Undergo a Noncurative Chemotherapy for Advanced Cancer in a Phase I Immunotherapy Trial.
a NIH Clinical Center.
Adelaide
A
Doussau
b Retired Family Physician.
Clark B
CB
Hanmer
D006801:Humans; D007167:Immunotherapy; D009369:Neoplasms